Pharmaron, founded in 2004, is a leading life sciences service provider offering research, development, and manufacturing across drug discovery and clinical development for small molecules, biologics, and CGT. With 22,000+ staff, it operates in China, the U.S., and the U.K.

Asemblis is a Swiss biotech company developing scalable, human-relevant in vitro models for obesity and metabolic disorders. The company partners with industry and research organizations to support translational R&D and decision-making in drug development.

Swiss Rockets is dedicated to developing groundbreaking medicines that transform the treatment of cancer, infectious diseases, and autoimmune disorders – advancing more effective, equitable, and accessible healthcare for patients worldwide.